Synthesis, Molecular Docking, and Anticancer Activity of Novel Chalcone-Hydrazone Derivatives as Tubulin Polymerization Inhibitors

The colchicine-binding site of tubulin represents an attractive target for the development of microtubuledisrupting anticancer agents. In the present study, a focused series of chalcone-hydrazone derivatives (3a–3j) was designed and investigated using an integrated in silico approach combining molecular property assessment, molecular docking, and ligand-based quantitative structure–activity relationship (QSAR) analysis. The designed derivatives incorporated different para-substituents on the benzylidene ring to examine their influence on tubulin binding and predicted antiproliferative activity. Molecular docking against the colchicine-binding site of human α/β-tubulin (PDB ID: 1SA0) showed favorable binding profiles across the series, with docking scores ranging from −9.1 to −10.8 kcal/mol. Compound 3c, bearing a para-nitro substituent, exhibited the most favorable docking score (−10.8 kcal/mol) and established multiple interactions within the binding pocket, including hydrogenbonding interactions involving Asn258 and Gln247 and additional electrostatic complementarity with Lys254. QSAR analysis further provided favorable activity estimates for the investigated derivatives against MCF-7 and A549 cell lines. Compound 3c showed the lowest estimated IC₅₀ values of 0.8 µM and 1.2 µM, respectively, followed by compound 3j with estimated IC₅₀ values of 1.0 µM and 1.5 µM. Correlation analysis between docking affinity and QSAR-derived pIC₅₀ values showed R² values of 0.808 for MCF-7 and 0.814 for A549 cells. Structure–activity relationship analysis indicated that electron-withdrawing para-substituents generally favored the computational binding and activity profiles of the chalcone-hydrazone scaffold. Overall, compounds 3c and 3j were identified as promising computational leads for further experimental synthesis and biological evaluation as potential tubulin-targeting anticancer agents.

Authors

Institutions

Publication Details

Journal
International Journal of Drug Delivery Technology
Published
2026-11-16
DOI
https://doi.org/10.25258/ijddt.16.80s.93
Primary Topic
Heterocyclic Compound Synthesis and Bioactivity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Synthesis, Molecular Docking, and Anticancer Activity of Novel Chalcone-Hydrazone Derivatives as Tubulin Polymerization Inhibitors

Shahjalal Alam, Syeda Jabeen Fatima, Ramesh Kumari Dasgupta, Junmoni Nath et al.
2 links
International Journal of Drug Delivery Technology
Heterocyclic Compound Synthesis and Bioactivity
article

Synthesis, Molecular Docking, and Anticancer Activity of Novel Chalcone-Hydrazone Derivatives as Tubulin Polymerization Inhibitors

Shahjalal Alam, Syeda Jabeen Fatima, Ramesh Kumari Dasgupta, Junmoni Nath, Devakamma Lakumalla, Kasturi Vishwanathasetty Veerabhadrappa
article en

Abstract

The colchicine-binding site of tubulin represents an attractive target for the development of microtubuledisrupting anticancer agents. In the present study, a focused series of chalcone-hydrazone derivatives (3a–3j) was designed and investigated using an integrated in silico approach combining molecular property assessment, molecular docking, and ligand-based quantitative structure–activity relationship (QSAR) analysis. The designed derivatives incorporated different para-substituents on the benzylidene ring to examine their influence on tubulin binding and predicted antiproliferative activity. Molecular docking against the colchicine-binding site of human α/β-tubulin (PDB ID: 1SA0) showed favorable binding profiles across the series, with docking scores ranging from −9.1 to −10.8 kcal/mol. Compound 3c, bearing a para-nitro substituent, exhibited the most favorable docking score (−10.8 kcal/mol) and established multiple interactions within the binding pocket, including hydrogenbonding interactions involving Asn258 and Gln247 and additional electrostatic complementarity with Lys254. QSAR analysis further provided favorable activity estimates for the investigated derivatives against MCF-7 and A549 cell lines. Compound 3c showed the lowest estimated IC₅₀ values of 0.8 µM and 1.2 µM, respectively, followed by compound 3j with estimated IC₅₀ values of 1.0 µM and 1.5 µM. Correlation analysis between docking affinity and QSAR-derived pIC₅₀ values showed R² values of 0.808 for MCF-7 and 0.814 for A549 cells. Structure–activity relationship analysis indicated that electron-withdrawing para-substituents generally favored the computational binding and activity profiles of the chalcone-hydrazone scaffold. Overall, compounds 3c and 3j were identified as promising computational leads for further experimental synthesis and biological evaluation as potential tubulin-targeting anticancer agents.

International Journal of Drug Delivery TechnologyVol. 16(80s)
Techno India University (IN), Advanced Numerical Research and Analysis Group (IN), Brainware University (IN)
Good health and well-being
Heterocyclic Compound Synthesis and Bioactivity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon